Ftse Mib
34.546,41
0,25%
DAX
18.738,66
0,30%
S&P 500
5.307,01
-0,27%
NASDAQ
16.801,54
-0,18%
Bitcoin
69.628,29
0,76%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IGM Biosciences Inc (IGMS) IGM Biosciences Inc (IGMS) Notizie

IGMS

IGM Biosciences (IGMS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IGMS
DataOraFonteTitoloSimboloCompagnia
08/05/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
08/05/202422:10GlobeNewswire Inc.IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
08/05/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IGMSIGM Biosciences Inc
07/05/202413:00GlobeNewswire Inc.IGM Biosciences to Present at the 2024 RBCCM Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
17/04/202414:30GlobeNewswire Inc.IGM Biosciences Announces Refocusing of Sanofi CollaborationNASDAQ:IGMSIGM Biosciences Inc
10/04/202413:00GlobeNewswire Inc.IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IGMSIGM Biosciences Inc
07/03/202422:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IGMSIGM Biosciences Inc
07/03/202422:10GlobeNewswire Inc.IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
06/03/202401:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
01/02/202413:00GlobeNewswire Inc.IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IGMSIGM Biosciences Inc
03/01/202413:00GlobeNewswire Inc.IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
13/12/202323:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
05/12/202322:01GlobeNewswire Inc.IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway ExtensionNASDAQ:IGMSIGM Biosciences Inc
01/12/202311:32PR Newswire (US)Bulletin from Extraordinary General Meeting in Medivir AB (publ)NASDAQ:IGMSIGM Biosciences Inc
28/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IGMSIGM Biosciences Inc
21/11/202308:48PR Newswire (US)Medivir to present at the Erik Penser Bank Company EventNASDAQ:IGMSIGM Biosciences Inc
13/11/202323:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IGMSIGM Biosciences Inc
13/11/202322:10GlobeNewswire Inc.IGM Biosciences Announces Third Quarter 2023 Financial ResultsNASDAQ:IGMSIGM Biosciences Inc
07/11/202313:00GlobeNewswire Inc.IGM Biosciences to Present at Two Upcoming Investor ConferencesNASDAQ:IGMSIGM Biosciences Inc
06/10/202301:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
05/10/202313:29PR Newswire (US)Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cyclesNASDAQ:IGMSIGM Biosciences Inc
03/10/202322:05GlobeNewswire Inc.IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of DirectorsNASDAQ:IGMSIGM Biosciences Inc
06/09/202313:00GlobeNewswire Inc.IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
03/08/202322:10GlobeNewswire Inc.IGM Biosciences Announces Second Quarter 2023 Financial ResultsNASDAQ:IGMSIGM Biosciences Inc
19/07/202322:13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:IGMSIGM Biosciences Inc
07/07/202320:26Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IGMSIGM Biosciences Inc
03/07/202322:01GlobeNewswire Inc.IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:IGMSIGM Biosciences Inc
29/06/202301:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IGMSIGM Biosciences Inc
28/06/202323:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IGMSIGM Biosciences Inc
27/06/202323:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IGMSIGM Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IGMS

La tua Cronologia

COIN
IGUPGBP
IGUP Token
EU
IEJAH
BNPP EJAH iNav
COIN
XIDOUSD
XIDO FINANCE
USOTC
RNVA
Rennova Health (PK)
TSX
5031
Moi
BIT
P1JPB8
BNP Paribas Issuance
COIN
BANANAETH
Banana.finance
NASDAQ
SHPH
Shuttle Pharmaceuticals
BOV
CSED3M
Cruzeiro do Sul Educacio... ON
NASDAQ
HKACU
KOSPI
500058
S&p500 Vix S/t Futures E...
BOV
AALR3R
ALLIAR ON
COIN
AXLLLETH
AXiaL Entertainment Digital Asse
BOV
A1MD34R
Advanced Micro Devices
USOTC
LTCHW
Latch (CE)
LSE
IDUS
Ishr S&p 500-i
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network